Insights

Specialized Research Focus SOLTI's deep expertise in clinical trials for breast cancer and its expanding focus on other tumor types position it as a leader in oncological research. Businesses providing innovative therapeutics or diagnostic tools targeting these cancers could find valuable partnership or sales opportunities.

International Collaboration With a broad network of over 80 hospital centers across Spain, Portugal, France, and Italy, SOLTI offers a strategic platform for companies seeking to expand clinical research collaborations or conduct multi-center studies within Europe, opening doors for regional market entry and joint ventures.

Cutting-Edge Technology Use Utilization of advanced tools such as TensorFlow and Google Analytics indicates a focus on innovative data analysis and digital engagement, suggesting opportunities for tech firms offering AI, data management, or digital health solutions tailored for clinical research environments.

Funding and Growth Potential With revenues estimated between 10 and 25 million dollars, SOLTI demonstrates healthy growth and capacity for expanding clinical trial activities, which could be attractive for investors or suppliers offering infrastructure, CRO services, or funding for high-impact oncology projects.

Non-Profit with Educational Outreach As an organization committed to education for medical professionals and patients, SOLTI presents opportunities for medical device companies, pharmaceutical firms, or educational platform providers to collaborate on awareness campaigns, training programs, or patient engagement initiatives.

SOLTI #cancerresearch Tech Stack

SOLTI #cancerresearch uses 8 technology products and services including AlloyUI, YUI, TensorFlow, and more. Explore SOLTI #cancerresearch's tech stack below.

  • AlloyUI
    Javascript Frameworks
  • YUI
    Javascript Libraries
  • TensorFlow
    Machine Learning
  • Microsoft Office
    Office Suites
  • WordPress Block Editor
    Page Builders
  • Google Tag Manager
    Tag Management
  • Piwik PRO Core
    Web Analytics
  • Twitter
    Widgets

Media & News

SOLTI #cancerresearch's Email Address Formats

SOLTI #cancerresearch uses at least 1 format(s):
SOLTI #cancerresearch Email FormatsExamplePercentage
First.Last@gruposolti.orgJohn.Doe@gruposolti.org
68%
First.Middle@gruposolti.orgJohn.Michael@gruposolti.org
30%
FirLast@gruposolti.orgJohDoe@gruposolti.org
2%

Frequently Asked Questions

What is SOLTI #cancerresearch's official website and social media links?

Minus sign iconPlus sign icon
SOLTI #cancerresearch's official website is gruposolti.org and has social profiles on LinkedIn.

What is SOLTI #cancerresearch's NAICS code?

Minus sign iconPlus sign icon
SOLTI #cancerresearch's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does SOLTI #cancerresearch have currently?

Minus sign iconPlus sign icon
As of July 2026, SOLTI #cancerresearch has approximately 134 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Ceo: R. M. C.Cfo: M. P. V.Chief Clinical Operations Officer: L. V.. Explore SOLTI #cancerresearch's employee directory with LeadIQ.

What industry does SOLTI #cancerresearch belong to?

Minus sign iconPlus sign icon
SOLTI #cancerresearch operates in the Research Services industry.

What technology does SOLTI #cancerresearch use?

Minus sign iconPlus sign icon
SOLTI #cancerresearch's tech stack includes AlloyUIYUITensorFlowMicrosoft OfficeWordPress Block EditorGoogle Tag ManagerPiwik PRO CoreTwitter.

What is SOLTI #cancerresearch's email format?

Minus sign iconPlus sign icon
SOLTI #cancerresearch's email format typically follows the pattern of First.Last@gruposolti.org. Find more SOLTI #cancerresearch email formats with LeadIQ.

When was SOLTI #cancerresearch founded?

Minus sign iconPlus sign icon
SOLTI #cancerresearch was founded in 1995.
SOLTI #cancerresearch logo

SOLTI #cancerresearch

Research ServicesCatalonia, Spain51-200 Employees

SOLTI is an academic group dedicated to clinical cancer research based in Barcelona, Catalonia, Spain, with a 30-year track record. Its work centers on designing and conducting translational and clinical studies within an academic framework, initially in breast cancer but expanding to other tumor types. The organization coordinates a large research network comprising about 480 researchers across roughly 100 centers in Spain, Portugal and Ireland, with a central office employing over 60 staff, and operates as a nonprofit affiliated with the Sociedad Española de Oncología Médica (SEOM).

SOLTI focuses on developing state-of-the-art clinical trials featuring targeted therapeutics and incorporates translational research across its projects to advance breast cancer treatment and prognosis. It also runs medical education programs for physicians and patients and participates in international networks to promote excellence in the management of breast cancer.

Section iconCompany Overview

NAICS Code
5417 - Scientific Research and Development Services
Founded
1995
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $10M$25M

    SOLTI #cancerresearch's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    SOLTI #cancerresearch's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.